ScoreWhy is Axsome Therapeutics, Inc. ?
1
Positive results in Mar 26
- OPERATING CASH FLOW(Y) Highest at USD -70.72 MM
- NET PROFIT(HY) Higher at USD -101.58 MM
- RAW MATERIAL COST(Y) Fallen by -0.99% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 146.15%, its profits have risen by 32.4%
3
High Institutional Holdings at 86.25%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
- Along with generating 146.15% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Axsome Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Axsome Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Axsome Therapeutics, Inc.
138.04%
5.69
43.11%
S&P 500
22.24%
1.91
13.23%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
264.06%
EBIT Growth (5y)
-21.77%
EBIT to Interest (avg)
-26.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.20
Sales to Capital Employed (avg)
1.39
Tax Ratio
0.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
86.25%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
90.58
EV to EBIT
-46.48
EV to EBITDA
-49.07
EV to Capital Employed
-179.12
EV to Sales
12.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-198.50%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -70.72 MM
NET PROFIT(HY)
Higher at USD -101.58 MM
RAW MATERIAL COST(Y)
Fallen by -0.99% (YoY
NET SALES(Q)
At USD 191.2 MM has Grown at 19.78%
-14What is not working for the Company
ROCE(HY)
Lowest at -349.38%
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.58 times
OPERATING PROFIT(Q)
Lowest at USD -60.4 MM
PRE-TAX PROFIT(Q)
Lowest at USD -63.95 MM
NET PROFIT(Q)
Lowest at USD -63.95 MM
EPS(Q)
Lowest at USD -1.26
Here's what is working for Axsome Therapeutics, Inc.
Operating Cash Flow
Highest at USD -70.72 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
At USD 191.2 MM has Grown at 19.78%
over average net sales of the previous four periods of USD 159.62 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Raw Material Cost
Fallen by -0.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Axsome Therapeutics, Inc.
Pre-Tax Profit
At USD -63.95 MM has Fallen at -45.52%
over average net sales of the previous four periods of USD -43.95 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -63.95 MM has Fallen at -45.96%
over average net sales of the previous four periods of USD -43.82 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit
Lowest at USD -60.4 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -63.95 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -63.95 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -1.26
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Inventory Turnover Ratio
Lowest at 2.58 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
